Results from a double-blind, randomized OPT-PEACE trial showed that almost all patients (at low bleeding risk) who received antiplatelet therapy developed a gastrointestinal injury, although overt bleeding was infrequent. Further, it was found that dual antiplatelet therapy (DAPT) followed by Single Antiplatelet Therapy (SAPT) versus continued DAPT resulted in less GI injury…
Keep Reading
Add A Comment